All News

The pilot study recently received final approval and is anticipated to last five years.

Our sister publication, Nutritional Outlook, recently published an article about how hair health could turn into another promising market for CBD.

On October 25th, 2023, the GMP Collective presented the latest installment in their webinar series, When Things Go Wrong.

A recent report found that federal cannabis legalization could harm existing state markets where the plant is legal medically, recreationally, or both.

The study examined the health risks and made recommendations for safer products.

A survey conducted by EO Care, Inc., showed that Americans would be more inclined to use cannabis to treat their health conditions if they were guided by a clinician.

The recent statement highlighted a lack of research, provides recommendations, and called for unbiased education for clinicians.

Cannabis nursing as a specialty has been an involved and complicated work-in-progress for more than a decade with the American Cannabis Nurses Association as well as the Cannabis Nurses Network and many others. In this exclusive interview, healthcare professionals Laura Barrett-Nutting, MBA, BSN, RN, co-founder and Executive Director of the National Clinical Directors Consortium and owner of Ask Nurse Laura, Heather Manus, RN, founding member of Cannabis Nurses Network, Mary Lynn Mathre, President and co-founder of Patients Out of Time and Founding Member of the American Cannabis Nurses Association (ACNA), and Dawn-Marie Steenstra, LPN, SDC, QA, SCC, a Clinical Director of Dispensaries in Maryland, and a co-founder for the National Clinical Director Consortium discuss the transformative effects of the American Nurses Association's (ANA) official recognition of cannabis nursing as a specialty practice (1,2).

Our sister publication, Dermatology Times, discussed how cannabis-based personal care products suddenly seem ubiquitous all over the market, where CBD is a featured ingredient in everything from moisturizers and lotions to makeup.

The tribe recently issued its first medical cannabis card, marking a historic step in the state.

Ganjier's pioneering cannabis sommelier certification program, conducted both virtually and on its Humboldt County, California campus, is shaping a new generation of professionals who are set to elevate the standards and quality of cannabis products, filling a void that has long existed in the industry.

Legislation recently passed in the Australian state of Victoria will enable the testing of cannabis’ effects on driving safely.

A recent study conducted in Canada with over 1,200 participants has found that psilocybin may significantly alleviate psychological distress resulting from childhood trauma, particularly benefitting those with more severe adversity, suggesting its therapeutic potential in addressing long-lasting trauma-related symptoms.

A trailblazer in psilocybin studies, Dr. Roland Griffiths passed away at age 77 on October 16, 2023, of colon cancer.

The application window for cannabis business licenses in New York was extended.

The 18-month trial will study the effects of a cannabis extract as part of treatment for brain cancer.

Aurélien Rousseau, the Minister for Health of France, promises to roll out medical cannabis access to patients throughout the country.

Two senate bills, SB 302 and SB 700, were passed to California Governor Newsom where they were signed into law, expanding cannabis rights for both patients and employees.

A study found that cannabis users that were infected by the COVID-19 virus, experienced ‘better outcomes and mortality’ than non-cannabis users.

The ANA has formally announced their recognition of cannabis nursing as a specialty nursing practice.

A population-based, retrospective study looked at the associations between cannabis use and effects on heart health.

In Maine, a Portland City Council voted to partially decriminalize psychedelics.

Our sister publication, Contemporary Pediatrics, covered research published in the journal Pediatrics about the correlation between the degree of toxicity following pediatric ingestion of THC and the dose of THC.

The cannabis industry in Canada is suffering from product recalls due to harmful mold and mislabeling issues.

Various efforts to attract non-white participants to the study have not succeeded, putting the study in jeopardy.

One laboratory’s concerns lead to a closer look at Montana’s still-developing cannabis program.

The USDA has declared that it is safe to grow and breed hemp in the US.

Patient access to medical cannabis will increase greatly in the coming weeks.